Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study
Prognosis; Treatment results; Hamartoma tumour syndrome
| Autores: | , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:11351/13537 |
| Acceso en línea: | http://hdl.handle.net/11351/13537 |
| Access Level: | acceso abierto |
| Palabra clave: | Càncer - Prognosi Avaluació de resultats (Assistència sanitària) Càncer - Aspectes genètics ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome DISEASES::Neoplasms DISEASES::Neoplasms::Hamartoma::Hamartoma Syndrome, Multiple TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento ENFERMEDADES::neoplasias ENFERMEDADES::neoplasias::hamartoma::síndrome de hamartomas múltiples |
| id |
ES_3bc8085c8c83666dc5deedbd98f588e6 |
|---|---|
| oai_identifier_str |
oai:recercat.cat:11351/13537 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study |
| title |
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study |
| spellingShingle |
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study Hendricks, Linda Càncer - Prognosi Avaluació de resultats (Assistència sanitària) Càncer - Aspectes genètics ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome DISEASES::Neoplasms DISEASES::Neoplasms::Hamartoma::Hamartoma Syndrome, Multiple TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento ENFERMEDADES::neoplasias ENFERMEDADES::neoplasias::hamartoma::síndrome de hamartomas múltiples |
| title_short |
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study |
| title_full |
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study |
| title_fullStr |
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study |
| title_full_unstemmed |
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study |
| title_sort |
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study |
| dc.creator.none.fl_str_mv |
Hendricks, Linda Verbeek, Katja Schuurs-Hoeijmakers, Janneke H. M. de Putter, Robin Brems, Hilde Van Daele, Sien H. Torres López, Maite Balmaña, Judith |
| author |
Hendricks, Linda |
| author_facet |
Hendricks, Linda Verbeek, Katja Schuurs-Hoeijmakers, Janneke H. M. de Putter, Robin Brems, Hilde Van Daele, Sien H. Torres López, Maite Balmaña, Judith |
| author_role |
author |
| author2 |
Verbeek, Katja Schuurs-Hoeijmakers, Janneke H. M. de Putter, Robin Brems, Hilde Van Daele, Sien H. Torres López, Maite Balmaña, Judith |
| author2_role |
author author author author author author author |
| dc.contributor.none.fl_str_mv |
Institut Català de la Salut [Hendricks LAJ, Verbeek KCJ] Department of Human Genetics, Radboudumc expert centre for PHTS, Radboud university medical centre, Nijmegen, the Netherlands. Radboud Institute for Medical Innovation, Radboud university medical centre, Nijmegen, the Netherlands. [Schuurs-Hoeijmakers JHM] Department of Human Genetics, Radboudumc expert centre for PHTS, Radboud university medical centre, Nijmegen, the Netherlands. [de Putter R] Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium. European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, the Netherlands. [Brems H] European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, the Netherlands. Department of Human Genetics, University of Leuven, Leuven, Belgium. [Van Daele SH] Department of Human Genetics, University of Leuven, Leuven, Belgium. [Balmaña J] European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, the Netherlands. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Torres M] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain Vall d'Hebron Barcelona Hospital Campus |
| dc.subject.none.fl_str_mv |
Càncer - Prognosi Avaluació de resultats (Assistència sanitària) Càncer - Aspectes genètics ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome DISEASES::Neoplasms DISEASES::Neoplasms::Hamartoma::Hamartoma Syndrome, Multiple TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento ENFERMEDADES::neoplasias ENFERMEDADES::neoplasias::hamartoma::síndrome de hamartomas múltiples |
| topic |
Càncer - Prognosi Avaluació de resultats (Assistència sanitària) Càncer - Aspectes genètics ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome DISEASES::Neoplasms DISEASES::Neoplasms::Hamartoma::Hamartoma Syndrome, Multiple TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento ENFERMEDADES::neoplasias ENFERMEDADES::neoplasias::hamartoma::síndrome de hamartomas múltiples |
| description |
Prognosis; Treatment results; Hamartoma tumour syndrome |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 2025 2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11351/13537 http://hdl.handle.net/11351/13537 |
| url |
http://hdl.handle.net/11351/13537 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
BJC Reports;3 https://doi.org/10.1038/s44276-025-00157-y |
| dc.rights.none.fl_str_mv |
Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Nature Portfolio |
| publisher.none.fl_str_mv |
Nature Portfolio |
| dc.source.none.fl_str_mv |
Scientia reponame:Recercat. Dipósit de la Recerca de Catalunya instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| instname_str |
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| reponame_str |
Recercat. Dipósit de la Recerca de Catalunya |
| collection |
Recercat. Dipósit de la Recerca de Catalunya |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869406327742136320 |
| spelling |
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort studyHendricks, LindaVerbeek, KatjaSchuurs-Hoeijmakers, Janneke H. M.de Putter, RobinBrems, HildeVan Daele, Sien H.Torres López, MaiteBalmaña, JudithCàncer - PrognosiAvaluació de resultats (Assistència sanitària)Càncer - Aspectes genèticsANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::PrognosisANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment OutcomeDISEASES::NeoplasmsDISEASES::Neoplasms::Hamartoma::Hamartoma Syndrome, MultipleTÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronósticoTÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamientoENFERMEDADES::neoplasiasENFERMEDADES::neoplasias::hamartoma::síndrome de hamartomas múltiplesPrognosis; Treatment results; Hamartoma tumour syndromePronòstic; Resultats del tractament; Síndrome de tumor hamartomaPronóstico; Resultados del tratamiento; Síndrome de tumor hamartomaBackground: PTEN hamartoma tumour syndrome (PHTS) patients have a high hereditary risk of cancer, especially breast (BC), endometrial (EC), and thyroid cancer (TC). However, the prognosis of PHTS-related cancers is unknown. Methods: This European cohort study included adult PHTS patients with data from medical files, registries, and/or questionnaires. Overall survival (OS) was assessed using Kaplan-Meier analyses and were compared with sporadic cancer and the general population using standardized mortality (SMR) and relative survival rates (RSR). Survival bias was addressed using left-truncation. Results: Overall, 147 BC patients were included. The 10y-OS was 77% (95%CI = 66-90), decreasing with increasing stage from 90% (95%CI = 73-100) for stage 0 to 0% (95%CI = 0-0) for stage IV. BC relative survival was comparable to sporadic BC in the first two years (2y-RSR = 1.1; 95%CI = 1.1-1.1) and increasing thereafter (5y-RSR = 1.7; 95%CI = 1.6-1.7). For TC (N = 56) and EC (N = 35), 10y-OS was 87% (95%CI = 74-100) and 64% (95%CI = 38-100), respectively. Overall and cancer-specific mortality in female PHTS patients exceeded general population rates (SMR = 3.7; 95%CI = 2.6-5.0 and SMR = 2.7; 95%CI = 1.6-4.4). Conclusions: The prognosis of PHTS-related cancers was comparable to the general population. The higher overall mortality in PHTS patients is presumably related to their higher cancer incidence. These findings, and the high survival observed in early-stage cancer, emphasise the importance of recognising PHTS early to facilitate cancer surveillance.This work has been funded, in part, by the PTEN Research Foundation, a charity governed by English law (charity number 117358) to L.A.J.H. and J.R.V. under grant number RUM 17-002; and Horizon Europe to K.C.J.V. under grant number 101095483.Nature PortfolioInstitut Català de la Salut[Hendricks LAJ, Verbeek KCJ] Department of Human Genetics, Radboudumc expert centre for PHTS, Radboud university medical centre, Nijmegen, the Netherlands. Radboud Institute for Medical Innovation, Radboud university medical centre, Nijmegen, the Netherlands. [Schuurs-Hoeijmakers JHM] Department of Human Genetics, Radboudumc expert centre for PHTS, Radboud university medical centre, Nijmegen, the Netherlands. [de Putter R] Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium. European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, the Netherlands. [Brems H] European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, the Netherlands. Department of Human Genetics, University of Leuven, Leuven, Belgium. [Van Daele SH] Department of Human Genetics, University of Leuven, Leuven, Belgium. [Balmaña J] European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, the Netherlands. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Torres M] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, SpainVall d'Hebron Barcelona Hospital Campus202520252025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/11351/13537http://hdl.handle.net/11351/13537Scientiareponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésBJC Reports;3https://doi.org/10.1038/s44276-025-00157-yAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:11351/135372026-05-29T05:05:01Z |
| score |
15.812429 |